Disa Tehler, PhD.

Disa is Head of RNA Therapeutics at Abzu and our expert in RNA therapeutics.

Disa's expertise: Designing RNA therapeutics.

Exploring the future of RNA therapeutics with Disa.

Welcome to the world of Disa Tehler, Abzu’s Head of RNA Therapeutics and expert RNA therapeutic designer. Disa has over 15 years’ research experience in academia and pharma. Disa’s work stands at the forefront of integrating advanced RNA science with our proprietary AI, shaping the next generation of RNA-based treatments.

Select your favorite media.

Or simply browse all content about Disa.

Here we use the QLattice® to generate siRNA activity models from publicly available data to create insights that can be used to design active siRNAs.
Our proprietary technology and brilliant Abzoids ensure that each step that we help our partners take in their pipeline is actually a leap towards viable, in vivo success.
RNA Leaders Europe is the #1 event focused on the development of mRNA, RNAi, ASOs, oligonucleotides, vaccines, microRNAs, genome editing, wider nucleic acids & RNA targets.
Oligonucleotides Therapeutics Society (OTS) 2023 poster and keynote.
OTS is a forum to foster academic and industry-based research and development of oligonucleotide therapeutics.

About Disa Tehler, PhD:

Head of RNA Therapeutics.

Disa was awarded her PhD in Cellular and Molecular Biology from the University of Copenhagen, and she also holds an MSc in Biotechnology Engineering. She is an RNA expert and drug designer with 15+ years’ research experience in academia and pharma.

Disa prioritizes family when not training cross-fit or ballet, and her greatest pleasure is to cruise around in her vintage Volvo on a sunny day.

Disa Tehler, Lead Bioinformatician, Abzu

Disa Tehler lost in thoughts about drug design.

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.